One week later; 1.3MM shares trade in the first 15 min and the price moves only a few pennies. My conclusion - late, simple, naive, uninformed, call it what you want - is that none of the science or substance of ARIA counts for anything at this point. The stock is merely a symbol for trading.
So no point in doing anything until ASH. That's about 6 weeks away and should give ARIA time for speaking with the FDA (I assume there is the usual 30-day lead time there), announcements from the company about cost-savings/financing/partnering/not partnering/lawsuits/more clinical data/Rx updates/new pipeline and any other announcements the might get us out of the Land of Trading Targets.
Just my thoughts.....